日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial

FORUM试验中微小残留病灶对儿童急性淋巴细胞白血病造血干细胞移植疗效的影响

Balduzzi, Adriana; Glogova, Evgenia; Peters, Christina; Sedlacek, Petr; Dalle, Jean-Hugues; Locatelli, Franco; Meisel, Roland; Burkhardt, Birgit; Buechner, Jochen; Wachowiak, Jacek; Bierings, Marc; Staciuk, Raquel; Graphakos, Stelios; Güngör, Tayfun; Yesilipek, Akif; Svec, Peter; Palma, Julia; Krivan, Gergely; Diaz-de-Heredia, Cristina; Limido, Francesca; Ansari, Marc; Kalwak, Krzysztof; Bader, Peter; Ifversen, Marianne

Allogeneic HSCT for consolidation in pediatric refractory or relapsed ALK-positive anaplastic large cell lymphoma

异基因造血干细胞移植用于儿童难治性或复发性ALK阳性间变性大细胞淋巴瘤的巩固治疗

Knörr, Fabian; Zimmermann, Martin; Bader, Peter; Lang, Peter; Müller, Ingo; Basu, Oliver; Burkhardt, Birgit; Seidl, Jakob; Damm-Welk, Christine; Pichler, Herbert; Attarbaschi, Andishe; Meissner, Barbara; Beier, Rita; Woessmann, Wilhelm

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years

近年来,儿童再生障碍性贫血患者接受造血干细胞移植(HSCT)治疗,无论是否先进行免疫抑制治疗(IST),其疗效均相当。

Andresen, Felicia; Yoshimi, Ayami; Bader, Peter; Bierings, Marc; Bod'ová, Ivana; Bordon, Victoria; Buechner, Jochen; Burkhardt, Birgit; Dworzak, Michael; Erlacher, Miriam; Kállay, Krisztián; Labarque, Veerle; Locatelli, Franco; Malone, Andrea; Masmas, Tania; Müller, Ingo; Nöllke, Peter; Schmugge, Markus; Pawelec, Katarzyna; Sedlacek, Petr; Sevilla, Julian; Smith, Owen; Stary, Jan; Niemeyer, Charlotte; Strahm, Brigitte

Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening Program

TREC新生儿筛查中的综合征性先天性免疫缺陷:德国筛查项目的5年经验

Graafen, Lea; Speckmann, Carsten; Bakhtiar, Shahrzad; Bernuth, Horst V; Lehmberg, Kai; Bader, Peter; Baumann, Ulrich; Beier, Rita; Borte, Stephan; Brockow, Inken; Davies, E Graham; Hartmann, Maximilian; Holzer, Ursula; Klemann, Christian; Kreins, Alexandra Y; Krüger, Renate; Kontny, Udo; Laws, Hans-Jürgen; Meinhardt, Andrea; Morbach, Henner; Naumann-Bartsch, Nora; Rothoeft, Tobias; Schneider, Dominik T; Willasch, Andre; Worth, Austen; Seidel, Markus G; Albert, Michael H; Ehl, Stephan; Hauck, Fabian; Hönig, Manfred; Schulz, Ansgar; Schuetz, Catharina; Ghosh, Sujal

Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients

创新型间充质干细胞产品 MSC-FFM/MC0518 用于治疗类固醇难治性急性移植物抗宿主病的临床开发项目:成人和儿童患者的 2 项随机对照试验设计

Zeiser, Robert; Bönig, Halvard; Osswald, Elena; Pichlmeier, Uwe; Möller, Ann-Kristin; Tribanek, Michael; Lazarou-Wild, Maria; von der Weth, Renate; Pfeffermann, Lisa-Marie; Bader, Peter

Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults

一项针对儿童和青少年复发/难治性急性淋巴细胞白血病嵌合抗原受体T细胞治疗前桥接治疗的多国回顾性分析

Breidenbach, Maike; Bader, Peter; Attarbaschi, Andishe; Rossig, Claudia; Meisel, Roland; Metzler, Markus; Subklewe, Marion; Mueller, Fabian; Schlegel, Paul-Gerhardt; Teichert von Lüttichau, Irene; Bourquin, Jean-Pierre; Escherich, Gabriele; Cario, Gunnar; Lang, Peter; Coffey, Ramona; von Stackelberg, Arend; Willier, Semjon; Strahm, Brigitte; Peters, Christina; Feuchtinger, Tobias

Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP

32例JAGN1缺陷患者的扩展临床表型和治疗方式:ESID和EBMT IEWP的多中心研究

Fekadu-Siebald, Julia; Salzmann-Manrique, Emilia; Heusel, Jan Robert; Willasch, Andre; Hauck, Fabian; Gonzalez-Granado, Luis Ignacio; Chavoshzadeh, Zahra; Sharafian, Samin; Cuntz, Franziska; Baris, Safa; Finocchi, Andrea; Algeri, Mattia; Sherkat, Roya; Klaudel-Dreszler, Maja; Zeidler, Cornelia; Bellanné-Chantelot, Christine; Kindle, Gerhard; Beaupain, Blandine; Paillard, Catherine; Seidel, Markus; Bader, Peter; Albert, Michael H; Neven, Bénédicte; Donadieu, Jean; Bakhtiar, Shahrzad

Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM

在儿童急性淋巴细胞白血病(ALL)患者中,基于白消安或曲奥舒凡的预处理方案进行异基因造血干细胞移植(allo-HSCT)后,疗效相当:FORUM 研究结果

Kalwak, Krzysztof; Moser, Laura M; Pötschger, Ulrike; Bader, Peter; Kleinschmidt, Katharina; Meisel, Roland; Dalle, Jean-Hugues; Yesilipek, Akif; Balduzzi, Adriana; Krivan, Gergely; Goussetis, Evgenios; Staciuk, Raquel; Sedlacek, Petr; Pichler, Herbert; Svec, Peter; Gabriel, Melissa; Güngör, Tayfun; Bilic, Ernest; Buechner, Jochen; Renard, Marleen; Vettenranta, Kim; Ifversen, Marianne; Diaz-de-Heredia, Cristina; Stein, Jerry; Toporski, Jacek; Bierings, Marc; Peters, Christina; Ansari, Marc; Locatelli, Franco

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma

CAR-CIK 与 CAR-T:以新型细胞因子诱导的杀伤细胞作为 ErbB2+ 横纹肌肉瘤实体瘤免疫疗法的基准比较

Moser, Laura M; Heim, Catrin; Koschade, Sebastian E; Wendel, Philipp; Bozkurt, Süleyman; Harenkamp, Sabine; Kreyenberg, Hermann; Merker, Michael; Münch, Christian; Gradhand, Elise; Vogler, Meike; Ullrich, Evelyn; Bönig, Halvard; Klusmann, Jan-Henning; Bader, Peter; Wels, Winfried S; Rettinger, Eva

Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study

采用包括抗GD2免疫疗法在内的多模式治疗方案治疗高危神经母细胞瘤患者的长期预后和生活质量:一项回顾性队列研究

Flaadt, Tim; Rehm, Jonas; Simon, Thorsten; Hero, Barbara; Ladenstein, Ruth L; Lode, Holger N; Grabow, Desiree; Nolte, Sandra; Crazzolara, Roman; Greil, Johann; Ebinger, Martin; Abele, Michael; Holzer, Ursula; Döring, Michaela; Schulte, Johannes H; Bader, Peter; Schlegel, Paul-Gerhardt; Eyrich, Matthias; Lang, Peter; Klingebiel, Thomas; Handgretinger, Rupert